|
|
Link Between Hyperphosphatemia and Vascular Calcification Elucidated
|
| Link ID |
5393 |
| Title |
Link Between Hyperphosphatemia and Vascular Calcification Elucidated |
| Url |
http://www.medscape.com/viewarticle/573849?src=rss |
| Description |
In patients with chronic kidney disease, hyperphosphatemia stimulates vascular calcification by inducing the expression of osterix, an osteoblast transcription factor, in the neointima and tunica media, according to a report in the April 17th online issue of the Journal of the American Society of Nephrology. Reuters Health Information |
| Category |
Articles > Nephrology |
| Keywords |
|
| Date |
May 2, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Nephrology |
| 1. |
Urotensin Appears Cardioprotective in End-Stage Renal Disease
|
|
|
Although blockage of urotensin II (UTN) is being investigated as a treatment for heart failure and renal disease, new research suggests that high levels of UTN are actually cardioprotective in patients with end-stage renal disease (ESRD). Reuters Health Information
|
| 2. |
Multitarget Therapy Best for Treatment of Severe Lupus Nephritis
|
|
|
For inducing remission of class V+IV lupus nephritis, multitarget therapy with mycophenolate mofetil, tacrolimus, and steroids is superior to intravenous cyclophosphamide monotherapy, according to a report in the July 2nd online issue of the Journal of the American Society of Nephrology. Reuters Health Information
|
| 5. |
Chronic Kidney Disease: CT or MRI?
|
|
|
Reduced renal function patients are at risk for contrast-induced complications after contrast-enhanced imaging. How can these adverse effects be avoided? What guides imaging choice for these patients?
Applied Radiology
|
|
|
